By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
| Currency | US Dollars |
| Share Price | $ 151.40 |
| Change Today | $ 0.28 |
| % Change | 0.19 % |
| 52 Week High | $155.27 |
| 52 Week Low | $97.07 |
| Volume | 6,986,978 |
| Shares Issued | 1,246.00m |
| Market Cap | $188,644m |
| RiskGrade | 120 |
| Strong Buy | 10 |
| Buy | 13 |
| Neutral | 5 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 29 |

| Time | Volume / Share Price |
| 15:59 | 100 @ $151.39 |
| 15:59 | 276 @ $151.41 |
| 15:59 | 267 @ $151.40 |
| 15:59 | 282 @ $151.40 |
| 15:59 | 200 @ $151.40 |
You are here: research